NCT00075660View on ClinicalTrials.gov

3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

May 11, 2004

Primary Completion Date

October 4, 2005

Study Completion Date

September 22, 2008

Conditions
Kidney Cancer
Interventions
DRUG

triapine

Trial Locations (8)

T6G 1Z2

Cross Cancer Institute, Edmonton

V5Z 4E6

British Columbia Cancer Agency, Vancouver

R3E 0V9

CancerCare Manitoba, Winnipeg

L8V 5C2

Margaret and Charles Juravinski Cancer Centre, Hamilton

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

M5G 2C4

Toronto General Hospital, Toronto

H2L-4M1

Centre Hospitalier de l'Universite de Montreal, Montreal

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NCIC Clinical Trials Group

NETWORK

NCT00075660 - 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter